Lexaria Bioscience (LEXX) Market Capitalization (2021 - 2026)
Lexaria Bioscience (LEXX) recorded Market Capitalization of $9.52 million in fiscal Q3 2026 (quarter ended May 31, 2026), down 41.0% from $16.13 million a year earlier and down 13.8% from the prior quarter.
Lexaria Bioscience (LEXX) Market Capitalization (2021 - 2026) Analysis & Trends
For FY2025 (ended Aug 31, 2025), Lexaria Bioscience reported Market Capitalization of $5.82 million, down 77.5% from FY2024.
- Annual Market Capitalization has a four-year compound annual growth rate of -32.1% (FY2021 to FY2025).
- Across earlier fiscal years, Market Capitalization came in at $25.86 million in FY2024 (+272.4%), $6.94 million in FY2023 (-60.6%), $17.61 million in FY2022 (-35.5%) and $27.31 million in FY2021.
- The fiscal Q3 2026 figure is the lowest quarterly Market Capitalization since fiscal Q4 2023.
- On a year-over-year basis, Market Capitalization has declined for six consecutive quarters, with growth averaging 70.6% over the last eight quarters.
- Peak year-over-year performance for Market Capitalization in the last five years was growth of 790.1% in fiscal Q4 2024, against a decline of 77.5% in fiscal Q4 2025 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $11.05 million (Q2 2026), $17.23 million (Q1 2026) and $13.91 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.98 Bn | 1,134.57 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 643.66 Bn | 563.53 Bn | 17.30 Bn |
| 3 | AbbVie | 500.95 Bn | 474.06 Bn | 12.70 Bn |
| 4 | Merck | 358.08 Bn | 312.45 Bn | 12.21 Bn |
| 5 | Novartis Ag | 301.84 Bn | 265.83 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.25 Bn | 240.94 Bn | 12.86 Bn |
| 7 | Amgen | 241.42 Bn | 196.81 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 193.09 Bn | 167.28 Bn | 6.22 Bn |
| 9 | Pfizer | 171.63 Bn | 118.27 Bn | 10.94 Bn |
| 10 | Lexaria Bioscience | 2.56 Mn | -12.70 Mn | - |
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | 9.52 Mn |
| Feb 28, 2026 | 11.05 Mn |
| Nov 30, 2025 | 17.23 Mn |
| Aug 31, 2025 | 13.91 Mn |
| May 31, 2025 | 16.13 Mn |
| Feb 28, 2025 | 23.24 Mn |
| Nov 30, 2024 | 32.89 Mn |
| Aug 31, 2024 | 61.82 Mn |
| May 31, 2024 | 61.50 Mn |
| Feb 29, 2024 | 42.74 Mn |
| Nov 30, 2023 | 15.47 Mn |
| Aug 31, 2023 | 6.94 Mn |
| May 31, 2023 | 4.79 Mn |
| Feb 28, 2023 | 18.03 Mn |
| Nov 30, 2022 | 17.61 Mn |
| Aug 31, 2022 | 17.61 Mn |
| May 31, 2022 | 12.20 Mn |
| Feb 28, 2022 | 21.13 Mn |
| Nov 30, 2021 | 30.35 Mn |
| Aug 31, 2021 | 27.31 Mn |
Lexaria Bioscience Market Capitalization API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=market-capitalization&ticker=LEXX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "market-capitalization", "ticker": "LEXX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=market-capitalization&ticker=LEXX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();